Israel pressured the Palestinian National Authority to search for militants. The Palestinian National Authority admitted on the 12th that Palestinian security forces killed a 19-year-old civilian man during an operation in the West Bank city of Jenin earlier this week. Palestinian Islamic Resistance Movement (Hamas) accused the Palestinian National Authority of searching for "resistance fighters" and said that Palestine should avoid internal conflicts. According to Israeli media reports, the Israeli side pressured the Palestinian National Authority to intensify the search, and threatened that if the Palestinian security forces could not do it, the Israeli army would do it. (Xinhua News Agency)Putin signed a decree to extend the measures to counter the western oil price limit against Russia again. On December 13th, local time, according to the documents published on the Russian legal information portal, Russian President Vladimir Putin has signed an order to extend the special economic measures formulated because western countries impose price limits on Russian oil and petroleum products until June 30th, 2025. Since the law came into effect on February 1, 2023, the validity of the measures has been extended several times. The decree stipulates that if the contract directly or indirectly stipulates the price ceiling set by other countries, it is forbidden to export Russian petroleum and petroleum products according to the contract, and the signed ban applies to all supply stages before delivery to buyers. (CCTV News)Haitian Weiye, a soy sauce manufacturer, is reported to have hired a bank to handle the listing in Hong Kong. According to informed sources, Haitian Weiye, one of the largest condiment manufacturers in China, has hired CICC, Goldman Sachs and Morgan Stanley to handle the second listing in Hong Kong, which may raise at least $1.5 billion. According to people familiar with the matter, Haitian plans to submit a preliminary prospectus to the Hong Kong Stock Exchange as early as January.
Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months. Market News: US Secretary of State Blinken met with Iraqi Prime Minister in Baghdad to discuss the Syrian issue.
Market News: Director of South Korea's National Police Agency will be arrested.Guoyuan Securities: A special dividend plan was drawn up and announced by Guoyuan Securities. On December 13, 2024, the company held the 20th meeting of the 10th Board of Directors and the 11th meeting of the 10th Board of Supervisors, at which the Proposal on Special Dividend Plan was reviewed and approved. As of September 30, 2024, the accumulated undistributed profit of the company was 7.743 billion yuan, and the accumulated distributable profit of the parent company was 5.262 billion yuan. In order to enhance the investor's sense of gain and improve the investor's return level, the company has drawn up a special dividend plan: based on the existing total share capital of 4.364 billion shares, a cash dividend of 0.60 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 262 million yuan will be distributed. No bonus shares will be distributed, and capital will not be increased from the provident fund.Macron rejected our proposal and appointed one of his allies as Prime Minister. We will not enter the government, and Macron chooses to continue his policy.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14